In silico drug design and analysis of dual amyloid-beta and tau protein-aggregation inhibitors for alzheimer’s disease treatment

HIGHLIGHTS

• who: Nisha Job and collaborators from the Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA, USA have published the paper: In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimeru2019s Disease Treatment, in the Journal: Molecules 2023, 28, x FOR PEER REVIEW complexes of /2023/
• what: The primary reason for protein aggregation is the interaction between peptide residues of the protein. The TPSA designed inhibitor molecules in this work . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.